Behavioural Health Research Group
Our Team
Projects
In The Media
Photos
Michelle Roseman, Msc

E-mailmichelle.roseman@mail.mcgill.ca

Michelle Roseman

Funding: Master’s Training Award, Fonds de la recherche en santé Québec (FRSQ).

Michelle Roseman is a first-year medical student in the MDCM program at McGill University. Born and raised in Montreal, Michelle completed her Honours B.A. in Psychology at McGill University in 2008, and her M.Sc. in Psychiatry in 2012, under the supervision of Dr. Brett Thombs.

Michelle’s research with the Behavioural Health Research Group focuses on evidence review in medicine and behavioural health. Her M.Sc thesis investigated the reporting in systematic reviews and meta-analyses of conflicts of interest from included randomized controlled trials.She has also been involved in systematic reviews of screening for depression and general distress in cancer patients, cardiovascular care and perinatal care. Her current project is a systematic review of screening for depression in children and adolescents.

Publications

Peer-Reviewed Articles

Thombs BD, Roseman M, Coyne JC, de Jonge P, Delisle VC, Arthurs E, Levis B, Ziegelstein R. Does evidence support the American Heart Association's recommendation to screen patients for depression in cardiovascular care? An updated systematic review. PLoS ONE. 2013;8(1):e52654. [Impact Factor = 4.1]. (click here for abstract)

Thombs BD, Roseman M, Kloda LA. Depression screening and mental health outcomes in children and adolescents: A systematic review protocol. Systematic Reviews. 2012:1:58. [Impact factor = N/A]. (click here for abstract)

Roseman M, Turner EH, Lexchin J, Coyne JC, Bero LA, Thombs BD. Reporting of conflict of interest from drug trials in Cochrane reviews: A cross-sectional study. BMJ. 2012;345:e5155. [Impact Factor = 14.1] (click here for abstract)

Meijer A, Roseman M, Milette K, Coyne JC, Stefanek ME, Ziegelstein RC, Arthurs E, Leavens A, Palmer SC, Stewart DE, de Jonge P, Thombs BD. Depression screening and patient outcomes in cancer: A systematic review. PLoS ONE. 2011; 6: e27181. [Impact Factor = 4.4] (click here for abstract)

Magyar-Russell G, Thombs BD, Cai JX, Baveja T, Kuhl E, Singh PP, Barroso MMB, Arthurs E, Roseman M, Amin N, Marine J, Ziegelstein RC. The prevalence of anxiety and depression in adults with implantable cardioverter defibrillators: A systematic review. J Psychosom Res. 2011; 71; 223-31. [Impact Factor = 2.8] (click here for abstract)

Roseman M, Milette K, Bero L, Coyne JC, Lexchin J, Turner E, Thombs BD. Reporting of conflicts of interest in meta-analyses of trials of pharmacological treatments. JAMA. 2011; 305: 1008-17. [Impact Factor = 30.0] (click here for abstract)

Milette K, Roseman M, Thombs BD. Transparency of outcome reporting and trial registration of randomized controlled trials in psychosomatic and behavioural health research: A systematic review. J Psychosom Res. 2011; 70: 205-217. [Impact Factor = 2.8] (click here for abstract)

Knäuper B, McCollam A, Rosen-Brown A, Lacaille J, Kelso E, Roseman M. Fruitful plans: Adding mental imagery to implementation intentions increases fruit consumption. Psychol Health. 2011; 26:601-17. [Impact Factor = 1.6] (click here for abstract)

Steinberg T, Roseman M, Kasymjanova G, Dobson S, Lajeunesse L, et al. Prevalence of emotional distress in newly diagnosed lung cancer patients. Support Care Cancer. 2009; 17: 1493-1497. [Impact Factor = 2.1] (click here for abstract)

Knäuper B, Roseman M, Johnson PJ, Krantz LH. Using mental imagery to enhance the effectiveness of implementation intentions. Curr Psychol. 2009; 28: 181-186. (click here for abstract)

Lewin W, Knäuper B, Roseman M, Adler P, Malus M. Detecting and addressing adolescent issues and concerns: Evaluating the efficacy of a primary care previsit questionnaire.Can Fam Physician. 2009; 55: 742-3.e1-4. [Impact Factor = 1.4] (click here for abstract)

Letters to the Editor

Thombs BD, Roseman M, Arthurs E. Are fathers at risk for prenatal and postpartum depression? A critical look at the evidence. JAMA. 2010; 304: 961.

Roseman M, Milette K, Zhao Y, Thombs B. Is optimism associated with physical health? A commentary on Rasmussen et al. Ann Behav Med. 2010; 39: 204-6. (click here for abstract)

Invited Presentations

Roseman M. Reporting of Conflicts of Interest from Drug Trials in Cochrane Reviews. Montreal Chest Institute, Respiratory Epidemiology and Clinical Research Unit Seminar, Montreal, Quebec, Canada. March 2012.

Roseman M. Unreported Conflicts of Interest when Pharmacological Treatment Trials are Synthesized in Meta-analyses. Lady Davis Institute, Jewish General Hospital, Psychosocial Axis Seminar Series, Montreal, Quebec, Canada.. January 2011.

Roseman M. Hidden Conflicts of Interest in Meta-Analyses of Pharmacological Treatments. Montreal Chest Institute, Respiratory Epidemiology and Clinical Research Unit Seminar, Montreal, Quebec, Canada. October 2010.

Roseman M. Hidden Conflicts of Interest in Meta-Analyses of Pharmacological Treatments. McGill University, Faculty of Medicine, Department of Epidemiology, Biostatistics, and Occupational Health, 2009-2010 Seminar Series, Montreal, Quebec, Canada. May 2010.

Roseman M. Hidden Conflicts of Interest in Meta-Analyses of Pharmacological Treatments. Lady Davis Institute , Jewish General Hospital, First Annual Scientific Retreat, Montreal, Quebec, Canada. May 2010.

Roseman M. How transparent is evidence reporting in meta-analyses? An assessment of hidden conflicts of interests in meta-analyses of pharmacological treatments. Jewish General Hospital, Culture and Mental Health Research Unit, Montreal, Quebec, Canada. April 2010.

Oral Conference Presentations

Roseman M, Milette K, Bero L, Coyne JC, Lexchin J, Turner E, Thombs BD. Hidden conflicts of interests in meta-analyses of pharmacological treatments. Canadian Cochrane Collaboration 8th Annual Symposium, Ottawa, Ontario, Canada, May 2010.

Poster Presentations

Roseman M, Bero L, Coyne JC, Lexchin J, Turner E, Thombs BD. Reporting of conflicts of interest in Cochrane reviews of trials of pharmacological treatments. 2011 Cochrane Colloquium, Madrid, Spain. October 2011.

Roseman M, Milette K, Bero L, Coyne JC, Lexchin J, Turner E, Thombs BD. Hidden conflicts of interests in meta-analyses of pharmacological treatments. 2010 Joint Cochrane & Campbell Colloquium, Keystone, Colorado, October 2010.

Roseman M, Witkowski L, Kasymjanova G, Gagnon B, MacDonald N, Agulnik J, et al. Survival in bronchioloalveolar carcinoma: the role of inflammation. International Association for the Study of Lung Cancer (IASLC) 13th World Conference on Lung Cancer, San Francisco, California, August 2009.

Roseman M, Krantz L, Johnson P, Knäuper B. Combining implementation intentions with mental imagery increases goal achievement. Canadian Psychological Association (CPA) Convention, Montreal, Quebec, Canada, June 2009.

Roseman M, Knäuper B, Lewin W, Adler P, Malus M. Evaluating the efficacy of a primary care pre-visit questionnaire (Poster). North American Primary Care Research Group (NAPCRG) Annual Meeting, Vancouver, British Columbia, Canada, October 2007.

Media Coverage

International

What conflicts? Cochrane reviews & disclosure info,” Pharmalot, August 23, 2012 

Bias creeps into meta-studies: US medical journal,” Agence France Press, March 8, 2011.

Influential research misses financial conflicts,” Reuters, Hartford Courant, Chicago Tribune, March 8, 2011

Major drug review research fails to disclose funding sources,” Health Day News Report, U.S. News & World Report, Bloomberg Businessweek, MSN Health, March 8, 2011.

Scientists Often Ignore Financial Conflicts When Reviewing Drugs, Study Finds,” AOL Health, March 9, 2011.

National/Local

“ ‘Critical information’ from drug trials kept from doctors and patients: study.” Montreal Gazette, August 22, 2012 

Médicaments – Qui finance les essays cliniques? Les liens entre les chercheurs et l’industrie phamaceutique sont rarement relevés dans les publications médicales.” Le Devoir, March 9, 2011.

Sponsorship biases keep MDs in the dark: Conflicts of interest between researchers, pharmaceutical firms not fully disclosed,” Vancouver Sun, March 9, 2011

Medical studies affected by funding, study finds,” Montreal Gazette, March 9, 2011

Hidden hand can influence doctor's decisions: Researcher-drug company links may lead to conflict of interest,” Victoria Times Colonist, March 9, 2011

Undisclosed funding sources raise issue of bias in medical studies: Report,” Vancouver Province, Edmonton Journal, Regina Leader-Post, Saskatoon StarPhoenix, Windsor Star, Ottawa Citizen, Calgary Herald, March 9, 2011.

Les études sur les médicaments devraient mentionner leur source de financement,” La Presse Canadienne, March 9, 2011.

Medical journals still publishing studies that fail to reveal funding: study,” Globe and Mail, March 10, 2011

Awards

2013 – Mach-Gaensslen Foundation of Canada Student Grant, McGill Faculty of Medicine Summary Research Bursary Program ($3,125)

2013 – March 2013 Laureate - Fonds Santé, Étudiants-chercheurs étoiles, Fonds de recherche du Québec ($1,000)

2012 – McGill MedStar Award, McGill University ($1,000) 

2011 – Institute Community Support (ICS) Travel Award, Institute of Health Services and Policy          Research (IHSPR), Canadian Institutes of Health Research (CIHR) ($1,500) 

2011 – Birmingham Dennis Award, Department of Psychiatry, McGill University ($1,000) 

2011 - Principal’s Graduate Fellowship, McGill University ($2,500) 

2010-2012 - Master’s Training Award, Fonds de la recherche en santé Québec (FRSQ), ($15,000/year, declined remainder of first year of funding) 

2010 - Graduate Research Enhancement and Travel (GREAT) Award, Department of Psychiatry,    McGill University, 2010 ($700) 

2010 - 2011- Frederick Banting and Charles Best Master’s Award, Canadian Institutes of Health Research    (CIHR) ($17,500) 

2010 - Master’s Training Award, Fonds de la recherche en santé Québec (FRSQ), ($15,000/year,    declined remainder of first year of funding) 

2010 - Principal’s Graduate Fellowship, McGill University ($2,500) 2010 - Provost’s Graduate    Fellowship, McGill University ($1,500)